Patanjali Foods stock: 38% pledge risk, 2026 targets

Price snapshot and what the latest prints show

Patanjali Foods Ltd. was last seen around ₹419.95 on 08 Jun, 2026 (03:55 PM IST), with the feed showing a -0.12% move from the previous close of ₹420.45. Another line in the same data set mentions the stock being down 0.12% versus a previous share price of ₹427.25, indicating multiple reference points across sources. Separately, a price line shows ₹408.85, down ₹4.95 (-1.20%), again suggesting a different snapshot.

These variations matter because the broader narrative is about a stock that has remained under pressure for months, and single-day moves can look different depending on the exact timestamp or source. Still, the direction across the excerpts is consistent: the stock has been trading well below prior peaks and has struggled to regain momentum.

A stock under pressure: 52-week levels and longer-term drawdown

The excerpts point to a sharp gap between current levels and past highs. One passage states Patanjali Foods hit a high of ₹653 on 22 July 2025, while another cites a 52-week high of ₹663.96. Against the cited current zone, the latter implies a decline of about 31.7%.

Over the last 12 months, the stock is reported to be down 27.29%, compared with the Sensex up 1.30% over the same period. On a day described as a broader sell-off, the Sensex is said to have fallen by nearly 2%, and Patanjali Foods underperformed its sector by 0.83%, highlighting stock-specific pressure on top of market weakness.

The overhang investors keep returning to: promoter pledge at 38.09%

A recurring risk flag in the provided text is the promoter share pledge of 38.09%. High pledging is often watched closely because it can amplify downside risk during drawdowns, particularly when prices fall and lenders seek additional collateral.

The excerpts also connect the pledged stake to the weak technical setup, suggesting that negative sentiment has been hard to reverse even when some business indicators appear constructive. The pledge figure is explicitly cited and remains one of the clearest, most quantifiable concerns highlighted in the material.

Technical setup: “bearish” grades and moving-average signals

On the technical side, the stock is described as trading below major moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), which is presented as evidence of sustained selling pressure. One technical read calls the setup “predominantly bearish.”

MarketsMOJO’s framework is also referenced as rating the stock ‘Sell’ as of 02 January 2026, citing a combined view across Quality, Valuation, Financial Trend, and Technicals. In the same excerpt, the stock is described as expensive, with P/B of 5, and another valuation line mentions a P/E of 42x.

Analyst recommendations: strong buy on one feed, mixed elsewhere

The material includes multiple recommendation summaries. One section shows “Mean Recos by 4 Analysts: STRONG BUY”, and a recommendation ladder indicating most weight on the buy side. Another excerpt mentions a broader consensus described as Hold (mix of Buy, Hold, & Sell), alongside long-term target references.

Targets also vary by source. One segment says a short-term target of ₹530 is possible “in the coming weeks” for high-risk traders, while a separate long-term target set lists an average 12-month target of ₹570.10, with additional figures including ₹540.10 as an average one-year target and a stated forecast range (including ₹500.20 low and ₹550.12 high in one line). Another line mentions an analyst target range between a high of ₹550.90 and a low of ₹410.10.

Management commentary: monsoon risk, FY27 growth expectations

Alongside market discussion, the text includes management-style commentary on business expectations. A delayed monsoon is described as likely to impact demand. Guidance-like statements include expected EBITDA growth of around 12-15% in FY27.

Within FMCG and home and personal care (HPC), management commentary highlights optimism for the largest category: “15% plus growth in the oral care” business in FY27. These statements are presented as forward expectations rather than reported results, and they sit in contrast with the stock’s weak price trend.

Acquisition stance: “nothing on cards”

The provided transcript also includes a clear message on inorganic growth. Management says they are careful on acquisitions and are not moving ahead with anything right now, adding that there is “nothing on cards.”

For investors, this is relevant because it frames the near-term strategy as execution-led rather than driven by deals, at a time when the stock is already dealing with valuation and sentiment questions.

Oil palm EBITDA ramp: the numbers management put on the table

Another operational thread is oil palm. Management commentary anticipates oil palm will continue to grow by adding ₹50-70 crore of EBITDA each year. The same passage says “this year we should cross ₹400 crore plus,” and then looks further out: in 5 to 6 years, the business could be ₹700-800 crore of EBITDA.

These are specific numeric expectations in the text, and they explain why parts of the narrative mention a disconnect between improving business metrics and the market’s pricing of risk.

Key figures mentioned across the excerpts

What the mix of signals means for investors

The excerpts present a stock where price action and risk metrics are dominating the narrative. The technical readings described as bearish, along with the 38.09% promoter pledge, help explain why the stock has underperformed the broader market even as some operating expectations are positive.

At the same time, the material notes “strong profit growth and record sales” without providing specific quarterly numbers in the excerpt. That leaves readers with a partial but important point: the debate is less about whether the company has operating levers, and more about whether the market is applying a risk discount due to pledging, valuation, and persistent bearish momentum.

Conclusion

Patanjali Foods is trading far below its cited 52-week highs, with multiple feeds pointing to sustained weakness and a key overhang in the form of 38.09% promoter pledging. Management commentary, however, outlines FY27 growth expectations, including 12-15% EBITDA growth and 15%+ oral care growth, plus a sizable oil palm EBITDA ambition. The next leg of investor attention, based on the excerpts, is likely to remain anchored to technical levels and how the market weighs business execution against balance-sheet and sentiment risks.